Mallinckrodt files for bankruptcy protection after U.S. opioid lawsuit

12.10.2020 - Korneychuk Evgeniya
Mallinckrodt files for bankruptcy protection after U.S. opioid lawsuit

Pharmaceutical company Mallinckrodt Plc filed for Chapter 11 bankruptcy protection on Monday after the firm faced lawsuits alleging its involvement in the U.S. opioid epidemic and lost a court battle to avoid paying higher rebates to state Medicaid programs for its top-selling drug.

The company listed both assets and liabilities in the range of $1 billion to $10 billion, according to a filing with the U.S. Bankruptcy Court for the District of Delaware.

Mallinckrodt declared back in February that it has plans of having its generic drug business file for bankruptcy as part of a tentative $1.6 billion opioid settlement resolving claims by state attorneys general and U.S. cities and counties.

On August 4, the drugmaker warned that its parent company could also file for Chapter 11 protection after a judge permitted the federal government to force it to pay higher rebates to state Medicaid programs for its multiple-sclerosis drug H.P. Acthar Gel.

Over 3,000 lawsuits have been filed against various drug manufacturers, accusing them of engaging in deceptive marketing which promoted the use of addictive painkillers and fueled an epidemic that since 1999 has resulted in more than 450,000 overdose deaths.

Risk disclaimer "Market Solutions Ltd – Suite 305 Griffith Corporate Centre P.O. Box 1510 Beachmont, Kingstown, St Vincent and the Grenadines is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0128 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of Market solutions Ltd and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from umarkets.ai or Market Solutions limited." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue
×

Help with deposit?